BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $579.83M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-68.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $578.10M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-36.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $576.84M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $101.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $575.63M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $142.00K.
BLACK DIAMOND THERAPEUTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $8.00K | $579.83M | $-68.00K | $-483.68M | $96.09M | 3 month · $1.51M | (m) |
| 2026-03-31 | $0.00 | $8.00K | $578.10M | $-36.00K | $-473.78M | $104.30M | 3 month · $1.45M | (m) |
| 2025-12-31 | $0.00 | $8.00K | $576.84M | $101.00K | $-464.74M | $112.21M | 12 month · $6.63M | (m) |
| 2025-09-30 | $0.00 | $8.00K | $575.63M | $142.00K | $-449.62M | $126.15M | 3 month · $1.74M | (m) |
| 2025-06-30 | $0.00 | $7.00K | $573.75M | $-25.00K | $-441.13M | $132.61M | 3 month · $1.78M | (m) |
| 2025-03-31 | $0.00 | $7.00K | $572.09M | $-19.00K | $-430.56M | $141.52M | 3 month · $1.70M | (m) |
| 2024-12-31 | $0.00 | $7.00K | $570.36M | $24.00K | $-487.11M | $83.28M | 12 month · $10.63M | (m) |
| 2024-09-30 | $0.00 | $7.00K | $568.43M | $107.00K | $-471.12M | $97.43M | 3 month · $1.99M | (m) |
| 2024-06-30 | $0.00 | $7.00K | $566.69M | $-115.00K | $-455.56M | $110.52M | 3 month · $5.29M | (m) |
| 2024-03-31 | $0.00 | $7.00K | $540.05M | $-95.00K | $-435.66M | $104.31M | 3 month · $1.71M | (m) |
| 2023-12-31 | $0.00 | $7.00K | $534.19M | $-27.00K | $-417.43M | $116.74M | 12 month · $9.60M | (m) |
| 2023-09-30 | $0.00 | $7.00K | $532.70M | $-364.00K | $-398.02M | $134.32M | 3 month · $2.75M | (m) |
| 2023-06-30 | $0.00 | $5.00K | $457.87M | $-661.00K | $-375.02M | $82.20M | 3 month · $2.65M | (m) |
| 2023-03-31 | $0.00 | $5.00K | $455.23M | $-1.18M | $-355.86M | $98.19M | 3 month · $2.67M | (m) |
| 2022-12-31 | $0.00 | $5.00K | $452.50M | $-1.82M | $-334.99M | $115.69M | 12 month · $12.20M | (m) |
| 2022-09-30 | $0.00 | $5.00K | $449.62M | $-2.49M | $-313.91M | $133.23M | 3 month · $2.66M | (m) |
| 2022-06-30 | $0.00 | $5.00K | $446.91M | $-2.29M | $-292.26M | $152.37M | 3 month · $3.25M | (m) |
| 2022-03-31 | $0.00 | $5.00K | $443.66M | $-1.77M | $-269.33M | $172.56M | 3 month · $3.38M | (m) |
| 2021-12-31 | $0.00 | $5.00K | $440.13M | $-414.00K | $-243.82M | $195.90M | 12 month · $14.04M | (m) |
| 2021-09-30 | $0.00 | $5.00K | $436.75M | $143.00K | $-217.95M | $218.95M | 3 month · $3.01M | (m) |
| 2021-06-30 | $0.00 | $5.00K | $433.68M | $211.00K | $-182.88M | $251.02M | 3 month · $4.56M | 6 month · $0.00 |
| 2021-03-31 | $0.00 | $5.00K | $428.94M | $335.00K | $-148.53M | $280.75M | 3 month · $3.09M | 3 month · $0.00 |
| 2020-12-31 | $0.00 | $5.00K | $425.36M | $614.00K | $-118.22M | $307.76M | 12 month · $7.76M | 12 month · $16.00K |
| 2020-09-30 | (m) | $5.00K | $422.06M | $875.00K | $-95.60M | $327.35M | 3 month · $2.00M | (m) |
| 2020-06-30 | (m) | $5.00K | $419.79M | $1.01M | $-77.69M | $343.12M | 3 month · $1.42M | 6 month · $16.00K |
| 2020-03-31 | (m) | $5.00K | $418.38M | (m) | $-63.12M | $355.26M | 3 month · $1.88M | 3 month · $16.00K |
| 2019-12-31 | $0.00 | $1.00K | $3.81M | $0.00 | $-50.97M | $-47.16M | 12 month · $3.64M | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $-39.79M | 3 month · $850.00K | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $-31.37M | 3 month · $192.00K | 6 month · $0.00 |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $-19.28M | 3 month · $91.00K | 3 month · $0.00 |
| 2018-12-31 | (m) | $1.00K | $169.00K | (m) | $-15.71M | $-15.54M | 12 month · $64.00K | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | $-6.67M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |